Publicaciones en las que colabora con Javier Gil Goikouria (33)

2020

  1. Synovial fluid peptidase activity as a biomarker for knee osteoarthritis clinical progression: A cross-sectional study

    Bone and Joint Research, Vol. 9, Núm. 11, pp. 789-797

2014

  1. Altered glutamyl-aminopeptidase activity and expression in renal neoplasms

    BMC Cancer, Vol. 14, Núm. 1

2012

  1. Regulation of human sperm motility by opioid receptors

    Andrologia, Vol. 44, Núm. SUPPL.1, pp. 578-585

  2. The impact of peptidase activity on clear cell renal cell carcinoma survival

    American Journal of Physiology - Renal Physiology, Vol. 303, Núm. 12

2007

  1. Cystinyl aminopeptidase activity is decreased in renal cell carcinomas

    Regulatory Peptides, Vol. 144, Núm. 1-3, pp. 56-61

  2. Ontogeny of prolyl endopeptidase and pyroglutamyl peptidase I in rat tissues

    Regulatory Peptides, Vol. 139, Núm. 1-3, pp. 52-58

2006

  1. Expression and localization of δ-, κ-, and μ-opioid receptors in human spermatozoa and implications for sperm motility

    Journal of Clinical Endocrinology and Metabolism, Vol. 91, Núm. 12, pp. 4969-4975

2005

  1. Nutritional intake is soccer players of different ages

    Journal of Sports Sciences, Vol. 23, Núm. 3, pp. 235-242

2004

  1. Peptide metabolism and the control of body fluid homeostasis

    Current Medicinal Chemistry: Cardiovascular and Hematological Agents, Vol. 2, Núm. 3, pp. 219-238

2003

  1. Aminopeptidases in visceral organs during alterations in body fluid volume and osmolality

    Peptides, Vol. 24, Núm. 9, pp. 1367-1372

  2. Effect of aging on rat tissue peptidase activities

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 58, Núm. 9, pp. 792-797

2002

  1. Distribution of prolyl endopeptidase activities in rat and human brain

    Neurochemistry International, Vol. 40, Núm. 4, pp. 337-345

  2. Effect of the disruption of body fluid balance on pyroglutamyl aminopeptidase (Type-1) in rat brain structures

    Neuropeptides, Vol. 36, Núm. 5, pp. 333-340

2001

  1. Effects of hydrosaline treatments on prolyl endopeptidase activity in rat tissues

    Regulatory Peptides, Vol. 101, Núm. 1-3, pp. 141-147

  2. Interactions among challenges of hydromineral balance, angiotensin-converting enzyme, and cystine aminopeptidase

    Peptides, Vol. 22, Núm. 12, pp. 2137-2144

  3. Regional and subcellular distribution of soluble aminopeptidase in the human and the rat brain: A comparative study

    Neuropeptides, Vol. 35, Núm. 5-6, pp. 276-284

2000

  1. Subcellular distribution of pyroglutamyl-peptidase I activity in the developing rat cerebellum

    Developmental Neuroscience, Vol. 22, Núm. 4, pp. 264-273

  2. Subcellular ontogeny of brain pyroglutamyl peptidase I

    Peptides, Vol. 21, Núm. 4, pp. 509-517

1999

  1. Effect of imipramine on enkephalin-degrading peptidases

    European Neuropsychopharmacology, Vol. 9, Núm. 6, pp. 493-499

  2. Effect of lithium treatments on the tyrosine-aminopeptidase activities in the rat brain and the pituitary gland

    Arzneimittel-Forschung/Drug Research, Vol. 49, Núm. 10, pp. 816-819